Mobile Health Program for Heart Defects
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a mobile health program called Heart2Heart, designed for teens with congenital heart disease (a heart condition present at birth). The goal is to determine what teens like about the app and whether they find it easy to use. Participants will complete online surveys, use the app, and join an interview to share their thoughts. Teens aged 12 to 18 with this heart condition are suitable for the trial, provided they can participate in surveys and interviews in English and remain in the U.S. during the study. As an unphased trial, this study offers a unique opportunity for teens to shape a tool that could enhance their health management.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this mobile health program is safe for teens with congenital heart disease?
Research has shown that the Heart2Heart mobile health program is undergoing testing to assist teens with congenital heart disease. As a mobile app, it lacks the typical risks associated with drug trials or medical procedures. No reports of negative effects have emerged from using mobile health tools like Heart2Heart. The program offers information and interactive features to educate teens on maintaining health. While traditional safety data, such as side effects, do not apply, the program is intended to be safe for users.12345
Why are researchers excited about this trial?
Researchers are excited about Heart2Heart because it offers a fresh approach to managing congenital heart disease in teens. Unlike traditional treatments that focus on medication or surgery, Heart2Heart is a mobile health program that provides educational content and interactive tools directly to a teenager's smartphone. This accessibility encourages teens to engage with their health in a more proactive way, potentially leading to better long-term outcomes by fostering healthy habits. Additionally, its interactive features are designed to keep teens interested and informed, which is a unique advantage over standard care options.
What evidence suggests that this mobile health program is effective for teens with congenital heart disease?
Research has shown that mobile health programs can enhance the quality, access, and efficiency of health care for specific groups, such as those with congenital heart disease (CHD). In this trial, participants in the Mobile Health Program arm will access Heart2Heart, a mobile health program specifically designed for teens with CHD. While specific data on Heart2Heart's effectiveness is not yet available, mobile health tools have shown promise in helping teens learn to manage their health. These programs often include interactive features and information that guide users in making healthier choices. For teens with CHD, this approach could improve their understanding and management of their condition. Early indications suggest that Heart2Heart might effectively educate and support teens in maintaining health with CHD.12567
Are You a Good Fit for This Trial?
This trial is for teens aged 12-18 with structural congenital heart disease. They'll be asked to use a mobile health program, Heart2Heart, aimed at educating them about their condition and promoting healthy choices.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants interact with the Heart2Heart mobile health program and complete two online surveys
Follow-up
Participants are monitored for satisfaction and usability of the mobile health program
What Are the Treatments Tested in This Trial?
Interventions
- Heart2Heart
Trial Overview
The study tests the Heart2Heart mobile health program's user satisfaction and ease of use among teens with congenital heart disease through surveys, interaction with the app, and an interview.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants in this arm will receive access to Heart2Heart. Heart2Heart is a mobile health program for teens with congenital heart disease. It includes information and interactive features to help teens learn about staying healthy with congenital heart disease.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kristen Fox
Lead Sponsor
Ohio State University
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Citations
Mobile Health Program for Teens With Congenital Heart ...
It includes information and interactive features to help teens learn about staying healthy with congenital heart disease .
Mobile Health Program for Teens With Congenital Heart ...
It includes information and interactive features to help teens learn about staying healthy with congenital heart disease.
Mobile health monitoring of children with CHDs
Background: Mobile health has been shown to improve quality, access, and efficiency of health care in select populations. We sought to evaluate ...
Mobile Health Program for Teens With Congenital Heart
The goal of this clinical trial is to understand what teens with congenital heart disease like and want in a mobile health program that helps them learn ...
Public Health Approach to Improve Outcomes for ...
Emerging data suggest that older individuals with CHD are at increased risk for mortality, driven by coronary artery disease, heart failure, and ...
Mobile health in adults with congenital heart disease
Many adults with congenital heart disease (CHD) are affected lifelong by cardiac events, particularly arrhythmias and heart failure.
7.
research.chop.edu
research.chop.edu/cornerstone-blog/research-heroes-heart-to-heart-how-the-readman-family-supports-cardiac-researchResearch Heroes: Heart to Heart - How the Readman Family ...
The trial addressed many critical concerns nurses had for infants with complex congenital cardiac defects who require increased monitoring ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.